Primary-source record
Decision-gradeFDA approval
Omeros Corporation · FDA licenses Yartemlea (narsoplimab-wuug)
FDA's Purple Book lists BLA 761152 (Yartemlea, narsoplimab-wuug; Omeros Corporation, CDER) as licensed on 2025-12-23.
Key facts
- Filed
- Dec 23, 2025, 12:00 AM
- Event
- FDA approval
- Direction
- Positive
- Company
OMEROmeros- Asset
- Yartemlea
- Source
- Source
- Confidence
- Sourced